Phase 1 COVID19 Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
AGILE (Early Phase Platform Trial for COVID-19)
COVID19
University of Liverpool600 enrolled7 locationsNCT04746183
Recruiting
Phase 1Phase 2
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
COVID19
New York Medical College50 enrolled4 locationsNCT04896606
Recruiting
Phase 1
Covid-19 and Influenza Oral Vaccine Study
Influenza, Humancovid19 Infection
Vaxine Pty Ltd100 enrolled1 locationNCT06355232
Recruiting
Phase 1Phase 2
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
Covid19 Virus Infection
All Natural Medicine Clinic, LLC100 enrolled1 locationNCT04790240
Recruiting
Phase 1
Safety and efficacy of intranasal delivery of BromAc® (Bromelain & Acetylcysteine) in swab positive SARS-CoV-2 COVID-19 patients
COVID19
Mucpharm Pty Ltd40 enrolled1 locationACTRN12620000788976